MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$7,324K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Provider liability
Stock-based compensation
Accounts payable and accrued exp...
Others
Negative Cash Flow Breakdown
Accounts receivable, net
Business acquisitions, net of ca...
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
9,734
3,710
10,585
9,807
Depreciation
145
146
159
165
Amortization of intangibles
3,211
3,135
2,498
2,601
Stock-based compensation
19,396
21,921
15,452
18,977
Deferred income taxes, net
1,155
2,528
1,534
6,666
Accounts receivable, net
59,604
112,774
-139,876
55,047
Prepaid expenses and other current assets
6,084
2,408
-1,439
-18,306
Other non-current assets and right-of-use assets
-494
-978
2,671
-1,289
Accounts payable and accrued expenses
10,455
-16,249
12,142
10,369
Provider liability
21,859
49,113
-53,186
37,630
Operating lease liabilities
-522
-510
-1,272
-409
Other long-term liabilities
861
945
944
1,640
Net cash used in operating activities
1,100
-49,465
127,500
51,994
Business acquisitions, net of cash acquired
11,430
-
91,312
0
Other
33
26
0
1,200
Distribution to non-controlling interest
-
-
1,345
-
Net cash used in investing activities
-11,463
-26
-91,312
-1,200
Proceeds from exercised stock options
826
774
3,490
431
Proceeds from non-controlling interest
2,213
-
0
0
Repurchase of non-controlling interest
0
11,444
0
-
Net cash (used in) provided by financing activities
3,039
-10,670
2,145
431
Net decrease in cash and cash equivalents
-7,324
-60,161
38,333
51,225
Cash and cash equivalents at beginning of period
419,524
479,685
441,352
491,149
Cash and cash equivalents at end of period
412,200
419,524
479,685
441,352
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from
non-controlling interest
$2,213K
Proceeds from exercised
stock options
$826K
(-79.98%↓ Y/Y)
Provider liability
$21,859K
(-73.08%↓ Y/Y)
Stock-based compensation
$19,396K
(-47.06%↓ Y/Y)
Accounts payable and
accrued expenses
$10,455K
(236.01%↑ Y/Y)
Net income
$9,734K
(4.29%↑ Y/Y)
Amortization of intangibles
$3,211K
(-21.09%↓ Y/Y)
Deferred income taxes,
net
$1,155K
(-56.76%↓ Y/Y)
Other long-term
liabilities
$861K
(662.75%↑ Y/Y)
Other non-current
assets and...
-$494K
(53.22%↑ Y/Y)
Depreciation
$145K
(-65.06%↓ Y/Y)
Net cash (used in)
provided by financing...
$3,039K
(-26.35%↓ Y/Y)
Net cash used in
operating activities
$1,100K
(106.84%↑ Y/Y)
Canceled cashflow
$66,210K
Net decrease in cash
and cash...
-$7,324K
(92.75%↑ Y/Y)
Canceled cashflow
$4,139K
Accounts receivable, net
$59,604K
(-50.94%↓ Y/Y)
Prepaid expenses and
other current assets
$6,084K
(-71.50%↓ Y/Y)
Operating lease
liabilities
-$522K
(32.90%↑ Y/Y)
Net cash used in
investing activities
-$11,463K
(87.13%↑ Y/Y)
Business acquisitions,
net of cash acquired
$11,430K
(-87.17%↓ Y/Y)
Other
$33K
Buy us a coffee
Privia Health Group, Inc. (PRVA)
Privia Health Group, Inc. (PRVA)